MELK and cancer: On the other hand, the growth inhibitory effects of MELK-T1 on a broad panel of cancer cell lines indicate that MELK is an interesting therapeutic target for several cancers and that MELK-T1 is a very promising lead compound due to its combined effect on MELK activity and stability.